This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Exploratory Study on the Efficacy and Safety of Trastuzumab Rezetecan in the Treatment of HER2-Expressiong Advanced Solid Tumor | MicrobiomeTrials
← Back to trials NCT07631884
Exploratory Study on the Efficacy and Safety of Trastuzumab Rezetecan in the Treatment of HER2-Expressiong Advanced Solid Tumor Recruiting PHASE2 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2026-06-15Est. Completion: 2028-12-31
Enrollment target: 15 participantsOther microbiome trials you might be interested in EGFR Overexpression Locally Advanced Solid Tumor Metastatic Solid Tumor
This is a study for people with locally advanced or metastatic cancer for whom previous treatment was not successful. Ad…
Seoul, South Korea Est. completion Jun 2027
Recurrent Melanoma (Skin) Metastatic Melanoma Melanoma Stage IV Melanoma Stage III
In this first-in human, phase I/IIa study, the safety and efficacy of \[212Pb\]VMT01, an alpha-particle emitting therape…
Orange, United States Est. completion Dec 31, 2027
Localized Clear Cell Renal Cell Carcinoma Resectable Clear Cell Renal Cell Carcinoma Stage II Renal Cell Cancer AJCC v8 Stage III Renal Cell Cancer AJCC v8 Stage IV Renal Cell Cancer AJCC v8
This phase II trial studies how well ivonescimab works prior to surgery in treating patients with high-risk clear cell k…
Duarte, United States Est. completion Sep 8, 2027